UnknownNot Applicable

Endoscopic Treatment of Non-variceal Upper GI-bleeding With High Risk of Recurrency - OTSC (Over-the-scope-clip) Versus Standard Therapy (STING2)

Germany120 participantsStarted 2017-09-01

Plain-language summary

Prospective-randomized multi-center trial. Patients with high risk of recurrent GI-bleeding (non-variceal) are identified and randomized into either endoscopic treatment with the OTSC \[Over The Scope Clip\] or endoscopic standard therapy. Hypothesis: Endoscopic therapy with OTSC is superior to standard therapy regarding technical success and rebleeding.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * upper GI-bleeding (non-variceal) with high risk of recurrency * 18 years and older Exclusion Criteria: * variceal-bleeding * under 18 years * pregnancy or nursing period * malignancy * need for surgical treatment (for example perforation with peritonitis)

What they're measuring

Persistent bleeding or Rebleeding with 7 days

Timeframe: 7 days

Trial details

NCT IDNCT03331224

SponsorKliniken Ludwigsburg-Bietigheim gGmbH

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-09-01

Contact for this trial

Karel Caca, Prof

004971419967201 karel.caca@kliniken-lb.de

View on ClinicalTrials.gov More Acute Upper Gastrointestinal Hemorrhage trials